1. Home
  2. CHMG vs ORGO Comparison

CHMG vs ORGO Comparison

Compare CHMG & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Chemung Financial Corp

CHMG

Chemung Financial Corp

N/A

Current Price

$74.35

Market Cap

339.8M

Sector

Finance

ML Signal

N/A

Logo Organogenesis Holdings Inc.

ORGO

Organogenesis Holdings Inc.

HOLD

Current Price

$2.38

Market Cap

299.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CHMG
ORGO
Founded
1833
1985
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
339.8M
299.8M
IPO Year
1995
2016

Fundamental Metrics

Financial Performance
Metric
CHMG
ORGO
Price
$74.35
$2.38
Analyst Decision
Hold
Strong Buy
Analyst Count
2
2
Target Price
$57.00
$8.50
AVG Volume (30 Days)
35.7K
689.4K
Earning Date
04-17-2026
05-07-2026
Dividend Yield
2.04%
N/A
EPS Growth
N/A
1600.00
EPS
1.91
N/A
Revenue
N/A
$564,169,000.00
Revenue This Year
$37.32
N/A
Revenue Next Year
$9.13
$26.27
P/E Ratio
$38.92
N/A
Revenue Growth
N/A
17.04
52 Week Low
$48.61
$2.04
52 Week High
$75.11
$7.08

Technical Indicators

Market Signals
Indicator
CHMG
ORGO
Relative Strength Index (RSI) 65.06 46.55
Support Level $69.35 $2.26
Resistance Level N/A $2.59
Average True Range (ATR) 2.01 0.11
MACD 0.12 0.00
Stochastic Oscillator 79.17 30.19

Price Performance

Historical Comparison
CHMG
ORGO

About CHMG Chemung Financial Corp

Chemung Financial Corp is a bank holding firm. Through its subsidiaries, the company provides various financial services, including demand, savings, and time deposits, commercial, residential, and consumer loans, letters of credit, wealth management services, employee benefit plans, insurance products, mutual funds, and brokerage services, among others. The company's reportable segments are Core Banking, Wealth Management (WMG) services, and Holding company and CFS. Maximum revenue is generated from the Core Banking segment, which derives revenue by attracting deposits from the general public and using such funds to originate different types of loans, and to invest in securities. The Wealth Management (WMG) services segment provides trust and investment advisory services to clients.

About ORGO Organogenesis Holdings Inc.

Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.

Share on Social Networks: